EX-99.3 4 dex993.txt AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D Exhibit 2 Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Essential Therapeutics, Inc. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original. Executed this 29th day of April, 2003. INTERNATIONAL BIOTECHNOLOGY TRUST PLC By: /s/ Andrew Barker ----------------------------------------- Title: Director -------------------------------------- SCHRODER INVESTMENT MANAGEMENT LIMITED By: /s/ John Spedding ----------------------------------------- Title: Secretary -------------------------------------- /s/ Tom Daniel -------------------------------------------- Tom Daniel /s/ Kate Bingham -------------------------------------------- Kate Bingham /s/ Eva Haas -------------------------------------------- Eva Haas